Masoondarou Pharmaceutical Co. (MDPC)

MASPORT®, Botulinum Toxin Type A, 150, 300, 500 units. First botulinum toxin in Iran and in middle east. Clinically proven products, similar to Dyspot®. Masport® has been Registered and marketed since 2014 Masoondarou Biopharma was established in 2007 as a knowledge-based company in Iran, by development of technology for production of biopharmaceutical products, human vaccines and new high-tech medicines to combat diseases and promote health in the country. • This company won the first rank in the Technopinners section in the 8th Sheikh Baha’i National Technopreneurship Festival in 2012 • This knowledge-based company tries to produce novel-technology based biotechnological drugs by attracting specialized and expert employees. MasoonDarou is the first and only pharmaceutical company in Iran that produces monovalent and polyvalent antitoxins of Clostridium botulinum, Haemophilus influenzae type B conjugate vaccine under the brand name MAS-Hib VAC®️ and Clostridium botulinum toxin type A under the brand name MASPORT¬®️. The products of MasoonDarou Company are of excellent quality and are produced according to American and European standards. The amount of production capacity in this company is several times more than the amount needed by the consumers in the country.In addition to fully meeting the needs of the country, the products of MasoonDarou company have been imported to all parts of the world’s markets in Asia, Europe, America, Africa and Oceania, and have been highly welcomed due to their high quality.